Skip to content
10-Q

Quarterly Report

THERABIOGEN, INC.

0001393905-12-000019

← back to feed
Filed
Jan 17, 2012 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2011 · Nov 30, 2011 57.56M sh
Operating Cash Flow Q3 2011 · Nov 30, 2011 −$737.1K
Operating Cash Flow Q3 2011 · Nov 30, 2010 −$882.05K
Cash And Equivalents Q3 2011 · Nov 30, 2011 $75.95K
Cash And Equivalents Q3 2011 · Nov 30, 2010 $36.68K
Cash And Equivalents Q3 2011 · Feb 28, 2010 $4.14K
Stockholders Equity Q3 2011 · Nov 30, 2011 $537.32K
Stockholders Equity Q3 2011 · Feb 28, 2011 $1.02M
Current Liabilities Q3 2011 · Nov 30, 2011 $2.2M
Current Liabilities Q3 2011 · Feb 28, 2011 $1.47M
Total Liabilities Q3 2011 · Nov 30, 2011 $2.2M
Total Liabilities Q3 2011 · Feb 28, 2011 $1.61M
Current Assets Q3 2011 · Nov 30, 2011 $535.11K
Current Assets Q3 2011 · Feb 28, 2011 $352.13K
Total Assets Q3 2011 · Nov 30, 2011 $2.74M
Total Assets Q3 2011 · Feb 28, 2011 $2.63M
Sga Expense Q3 2011 · Nov 30, 2011 $705.07K
Sga Expense Q3 2011 · Nov 30, 2011 $12.78M
Sga Expense Q3 2011 · Nov 30, 2010 $224.63K
Sga Expense Q3 2011 · Nov 30, 2010 $2.43M
Net Income Q3 2011 · Nov 30, 2011 $1.36M
Net Income Q3 2011 · Nov 30, 2011 −$15.43M
Net Income Q3 2011 · Nov 30, 2010 −$644.12K
Net Income Q3 2011 · Nov 30, 2010 −$3.15M
Cost Of Revenue Q3 2011 · Nov 30, 2011 $615.03K
Cost Of Revenue Q3 2011 · Nov 30, 2011 $776.29K
Cost Of Revenue Q3 2011 · Nov 30, 2010 $328.49K
Cost Of Revenue Q3 2011 · Nov 30, 2010 $328.49K
Revenue Q3 2011 · Nov 30, 2011 $693.18K
Revenue Q3 2011 · Nov 30, 2011 $902.3K
Revenue Q3 2011 · Nov 30, 2010 $278.51K
Revenue Q3 2011 · Nov 30, 2010 $278.51K